In a recent study titled “Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis,” published…
Margarida Azevedo, MSc
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Azevedo, MSc
Pharmaceutical company AB Science SA received orphan drug designation from the U.S. Food and Drug…
A recent study from Sweden’s KTH Royal Institute of Technology (KTH) revealed three proteins that are associated with the…
Massachusetts-based pharmaceutical company Biogen Idec Inc. has decided to rebrand the company with a shorter name and a new…
A research team at Penn Medicine recently found that hypermethylation is able to inhibit the development of Amyotrophic…
Results from a recent Phase I clinical trial in patients with Amyotrophic Lateral Sclerosis (ALS) showed a safe cell…
The ALS Association is inaugurating its new Nevada Chapter after the group joined 39 affiliates throughout the country to work in…
The Augie’s Quest initiative is hosting a 10 Year Reunion Bash on Friday, March 13. The event, which is being organized together…
‘My-own-voice,’ a system for patients who are losing their ability to speak due to diseases such as…
A new Phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT01938495) titled “Multi-Center, Randomized Controlled…